Neuroimaging

Neuroradiology is a branch of medical imaging focused on spotting abnormalities of the central and peripheral nervous system, spine, head and neck. These highly trained doctors use CT, MRI, X-ray and other techniques to diagnose strokes, tumors, aneurysms and other neurological conditions.

Thumbnail

An imaging AI 'epilepsy detective' could help cure treatment-resistant seizures

The tool can identify small focal cortical dysplasia on imaging that is typically missed by radiologists, bottom-of-sulcus dysplasia in particular.

Repetitive head impact in soccer players increases risk of brain damage, MRI shows

What's more, the damage observed on imaging could play a role in deteriorating cognitive performance.

Thumbnail

Researchers' testing of industrial dyes could lead to the development of dementia-specific imaging agents

There are dozens of different subtypes of dementia, and it can be a challenge to determine the exact type affecting a patient. 

stroke brain dementia alzheimer's puzzle mental health

Iron load on imaging could signal impending cognitive decline in asymptomatic patients

Using an advanced MRI technique, experts were able to measure tissue susceptibility and detect subtle variances in iron levels throughout different regions of the brain associated with memory.

Radiologist to lead new research on blast injuries in service members

The study, which will be funded by a $2.3 million grant from the U.S. Department of Defense, will harness the power of advanced MRI technology to visualize the brain in a way that has not previously been possible.  

Brainomix 360 triples number of stroke patients who regain functional independence.

AI software triples number of stroke patients who achieve functional independence

This week, health officials in the United Kingdom shared how an artificial intelligence-enabled platform has drastically improved stroke outcomes in the region.

NIH grants to fund study of molecular imaging in stroke care

NIH is hopeful the research will enable doctors to detect signs of stroke damage earlier, opening the door for them to initiate treatments in a timelier manner.

Thumbnail

FDA changes imaging recommendations for patients taking popular Alzheimer's drug

Leqembi (lecanemab) was approved by the FDA in 2023. It is an infusion drug that has been shown to reduce Alzheimer’s-related cognitive decline by up to 27%.